Abstract
Introduction: Chronic kidney disease is identified as a risk factor for severe cases of COVID-19 infection and is associated with worse clinical outcomes and higher mortality. Objective: To evaluate the profile of patients and the outcomes of COVID-19 infection in chronic kidney disease patients on dialysis admitted to a COVID-19 respiratory isolation sector. Methods: It is an observational, descriptive, retrospective study. Medical records of chronic dialysis patients hospitalized in respiratory isolation were analyzed, registered by gender, age, comorbidities, dialysis modality, hospitalization environment, need for mechanical ventilation, outcomes and length of stay. Symptoms on admission were listed, how many patients confirmed COVID-19 and which differential diagnoses of COVID-19 were ruled out. Results: 91 hospitalized patients were included (57.1% men) with a mean age of 58±17 years. The average length of stay was 7 days. Hypertension and diabetes were the most frequent comorbidities (87.9% and 35.1% respectively) and 89% of patients were undergoing hemodialysis (49.3% by AVF, 45.7% by tunneled catheter). Of the 10 patients on peritoneal dialysis, 40% required conversion to hemodialysis due to ultrafiltration failure. Among the symptoms on admission, 70.3% had dyspnea, 42.8% cough and 33% fever. COVID-19 infection was confirmed in 47.2% of patients (60.4% required ICU) and 37.2% died. Among those with COVID-19 ruled out, pulmonary congestion due to hypervolemia was the main differential diagnosis. Conclusion: Patients on a chronic dialysis program with COVID-19 infection, both hemodialysis and peritoneal dialysis, presented high rates of admission to intensive care beds and the need for mechanical ventilation, in addition to high mortality during hospitalization. Pulmonary congestion due to hypervolemia was an important differential diagnosis in those whose COVID-19 infection was ruled out.